Anti-CD19 [BU12]
AB00823-23.0-BT
ApplicationsFlow Cytometry, ImmunoPrecipitation, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman
TargetCD19
Overview
- SupplierAbsolute Antibody
- Product NameAnti-CD19 [BU12]
- Delivery Days Customer9
- Application Supplier NoteBU12 has been found to inhibit specific antibody responses by tonsillar mononuclear cells to influenza virus, and IgG secretion by B lymphoblastoid cell line stimulated with IL-6 (Callard 1992). BU12 has also been used in FACS and radio-iodinated antibody binding studies to determine the levels of CD19 expression on the surface of Ramos and NALM-6 cells (Flavell 2006).
- ApplicationsFlow Cytometry, ImmunoPrecipitation, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDBU12
- Gene ID930
- Target nameCD19
- Target descriptionCD19 molecule
- Target synonymsB4, CVID3, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, T-cell surface antigen Leu-12, differentiation antigen CD19
- HostRabbit
- IsotypeIgG
- Protein IDP15391
- Protein NameB-lymphocyte antigen CD19
- Scientific DescriptionThis chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.
- ReactivityHuman
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC41116161




![FACS analysis of human peripheral blood lymphocytes using GTX01455-08 CD19 antibody [HIB19] (PE). Solid lone : primary antibody Dashed line : isotype control antibody amount : 0.25 μg (5 μl)](https://www.genetex.com/upload/website/prouct_img/normal/GTX01455-08/GTX01455-08_20200428_FACS100_w_23053121_847.webp)
